Position in CATX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$321,465
+$110,895 QoQ
Shares Held
77,090
+0.7% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,402,735,897 across 83 Medical Devices names. CATX ranks #55 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,876,810 | $295,362,082 | |
| 2 | SYK |
Stryker Corp
|
633,935 | $208,304,701 | |
| 3 | MDT |
Medtronic plc
|
2,241,292 | $194,207,951 | |
| 4 | BSX |
Boston Scientific Corp
|
2,674,641 | $167,833,722 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,067,753 | $85,505,660 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
763,138 | $54,320,162 | |
| 7 | DXCM |
Dexcom Inc
|
772,557 | $48,516,579 | |
| 8 | STE |
STERIS plc
|
214,808 | $47,500,493 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,465 | 77,090 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $210,570 | 76,571 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $290,881 | 84,805 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $286,380 | 83,250 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $209,085 | 98,162 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $303,024 | 94,992 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,213,741 | 90,917 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $629,804 | 63,170 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||